Stock Market Manager Weekly Update: November 19th, 2021

Weekly UpdateNovember 19, 2021

Black Swan Connection Newsletter Signup

Breaking News-

Well it seems that Covid is here to stay, for a while anyway. Like myself I think a lot of people thought, ok, I got vaccinated that is the end of Covid in my life, but the small print mentioned that still doesn’t keep you from getting it and or passing it on.

The Austrian government announced a full lockdown again as new cases surge and that’s not good news for the market and neither is the Biden spending spree.

Yahoo Finance 11-19-21

“The news is hitting European markets hard this morning as fears mount that the virus and restrictions will spread across the continent again,” said Jim Reid, chief economist at Deutsche Bank, adding that “the curveball might be the U.S.” given lower rates of vaccination domestically than in Europe.

“So although all the headlines are in Europe at the moment, will the U.S. be more vulnerable than many European countries over the course of the full winter? Recent history suggests the U.S. have a higher bar for economic restrictions related to covid but it also has a lower vaccination rate than their European peers,” he added.

Read full report here

Corporate News

Sponsored by:

Donald Capital
The 21st Century Investment Bank Capital Raises + Strategic Advisory

Donald Capital is a boutique Investment Bank that focuses on raising capital for emerging growth companies in the U.S. and around the globe.

Ideally we like to work with Private and Public companies with a good management team, a compelling business plan, and the ability to gain market share.

For more information go to: www.DonaldCapital-NY.com

 
11-18-21 Perpetual Industries Inc. OTC (PRPI)
Perpetual Industries Reports Solid Third-Quarter Financial Growth

AUBURN, Ind., Nov. 18, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Perpetual Industries Inc. (OTCMARKETS:PRPI) (“Perpetual” or the “Company”), a diversified research and development company of energy-efficient technologies and products, is pleased to announce its financial and operating results for the third quarter of 2021.

Third Quarter 2021 Highlights for the Period Ending Sept. 30, 2021:

  • Gross revenues increased $5,142,718 in the nine months ending Sept. 30, 2021, over the same period in 2020
  • Gross profits increased $2,869,103 in the nine months ending Sept. 30, 2021, over the same period in 2020
  • Net income recorded of $566,676 in the three months ending Sept. 30, 2021, a growth of 443% over the same period in 2020
  • Cash reported on a consolidated basis of $3,471,679, an increase of 489% over year ending December 2020.
  • Total current assets recorded of $3,553,323, an increase of 450% over year ending December 2020.
Read Complete Release

 

11-01- 2021 Antibe Therapeutics Inc. OTC ATBF (TSXV:ATE)
Antibe Therapeutics Reports Q2 2022 Interim Financial and Operating Results

Otenaproxesul’s acute pain clinical program set to begin early next quarter
– Ended quarter with a $60 million cash position

TORONTO, November 16, 2021–(BUSINESS WIRE)–Antibe Therapeutics Inc. (TSX:ATE, OTCQX:ATBPF), a clinical stage company leveraging its unique hydrogen sulfide platform to develop safer medicines for pain and inflammation, has filed its financial and operating results for the fiscal quarter ended September 30, 2021.

“With the clinical program for post-operative pain slated to begin early next quarter and third-party commercial studies underway, the scientific and strategic review we initiated during the quarter will soon be yielding results,” commented Dan Legault, Antibe’s CEO. “Our goal is to rapidly deliver a safe and effective alternative for physicians, surgeons and patients who today must choose between GI-damaging NSAIDs and addictive, side effect-prone opioids. With a strong balance sheet and extensive safety and efficacy data on otenaproxesul already in hand, we are well-equipped to target one of the most intractable problems in healthcare.”

Read Complete Release

 

11-5-2021 CanB Corp (OTC  CANB)
Can B Corp. Reports 316% Revenue Growth to a Quarterly Revenue Record of $1.9 Million for its Third Quarter 2021

HICKSVILLE, NY / ACCESSWIRE / November 5, 2021 / Can B Corp. (OTCQB:CANB) (“Can B” or the “Company”), a health and wellness company specializing in developing, producing and selling hemp derived cannabinoid products, today announced the Company’s financial results for the third quarter ended September 30, 2021 (“Q3 2021”).

Key Financial Highlights during Q3 2021

  • Revenue increased 316% in 3rd quarter 2021 to $1.9 million compared to Q3 2020- (a trend expected to continue into subsequent quarters into 2023
  • Gross profit increased 261% to $1.4 million compared to Q3 2020
  • Total assets increased to 14.2 million
  • Total stockholders’ equity increased to $5.7 million

Read Complete Release

11-1-2021Guangdong Land Holdings Limited (HKSE 0124)

Greenridge Global Equity Research announced:

We are terminating coverage of Guangdong Land Holdings Limited in order to focus on other areas of interest to our institutional clients.  As a result our previous rating, estimates and target price should no longer be relied upon.

11-01- 2021 Antibe Therapeutics Inc. OTC ATBF (TSXV:ATE)
Antibe Therapeutics Outlines Plan for Otenaproxesul’s Acute Pain Program

TORONTO, November 01, 2021–(BUSINESS WIRE)–Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies for a wide range of inflammatory conditions, is pleased to provide further detail on otenaproxesul’s development plan for acute pain indications. Further to its October 14th press release, Antibe has now identified timing for the program’s key regulatory and development milestones for post-operative pain, the Company’s initial acute indication for otenaproxesul.

“With otenaproxesul’s impressive 14-day efficacy and GI safety profile, which is ideally suited for acute pain, we are well-positioned to rapidly bring to market a novel and safe non-opioid analgesic,” commented Dan Legault, Antibe’s CEO. “From a commercial standpoint, we see the $13 billion post-operative pain segment as an ideal springboard to the much broader acute pain market. Combined with the lack of innovation in oral analgesics and the urgent global need for non-addictive alternatives, we expect otenaproxesul to be especially attractive to potential partners. And with the option of funding the entire Phase III program with our current cash position, Antibe has a unique opportunity to shift the treatment paradigm of acute pain.”

Read Complete Release

10-26-2021 SRAX (NASDAQ SRAX)
SRAX to Present at the 2021 Ladenburg Virtual Tech Expo on November 18th, 2021
LOS ANGELES, November 08, 2021–(BUSINESS WIRE)–SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, announced that it will present at the Ladenburg Thalmann Virtual Technology Expo 2021, a one-day investor event featuring major technology companies, at 1:30 PM ET on November 18th.

Read Complete Release

10-26-2021 SRAX (NASDAQ SRAX)
The LD Micro Main Event, Hosted by SRAX, Featured Many Influential Companies – Replays Still Available

LOS ANGELES, October 26, 2021–(BUSINESS WIRE)–SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, hosted the 2021 LD Micro Main Event, both in-person in Los Angeles and virtually via their Sequire Virtual Events platform, on October 12-14th. Replays from all the companies are still available for viewing.

This event marked the first in-person conference for LD Micro in almost two years and brought physical and virtual elements together to form a truly unique experience.

The conference featured 139 companies, presenting for 25 minutes each. Though 1×1 meetings between investors and executives were only hosted at the physical event, investors all over the world were able to see the virtual presentations from these performing small and microcap companies.

Read Complete Report

10-28-21 Perpetual Industries Inc. OTC (PRPI)
Perpetual Industries Opens Its New Indiana Facility and Corporate Headquarters

Perpetual Industries announces it has moved into a new corporate facility in Auburn, Indiana.

AUBURN, Ind., Oct. 28, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Perpetual Industries Inc. (OTCMARKETS:PRPI) (“Perpetual” or the “Company”) is proud to announce it has moved into a new corporate facility in Auburn, Indiana. This impressive 22,000-square-foot facility, which serves as the Company’s new corporate headquarters, will give Perpetual more space to meet the growing demands of its research and development projects, as well as room to execute a large-scale Bitcoin mining center expansion for its cryptocurrency division.

Read Complete Release

10-14- 2021 Antibe Therapeutics Inc. OTC ATBF (TSXV:ATE)
Antibe Therapeutics Provides Update on Otenaproxesul and Expanded Drug Pipeline

TORONTO, October 14, 2021–(BUSINESS WIRE)–Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies for a wide range of inflammatory conditions, is pleased to provide an update following a full scientific and strategic review involving external experts and key opinion leaders. The key findings are:

  • Lead drug, otenaproxesul, ideally suited for US$13 billion post-operative pain market
  • Targets urgent need to reduce opioid prescriptions, with shorter path to market envisaged
  • Label expansion strategy potentially includes migraine, dysmenorrhea and dental pain
  • Enlarged pipeline addresses significant unmet medical needs, additional IP protection expected
  • Chronic pain program investigating alternative treatment regimens
  • Strong balance sheet fully funds multiple parallel clinical development programs

“In our comprehensive review, it became apparent that otenaproxesul’s remarkable potency, GI protection and overall safety profile should be leveraged for acute pain use,” commented Dan Legault, Antibe’s CEO.

Read Complete Release

Alternative Investments-

All kinds of buys in the hospitality Industry especially restaurant and bar properties

If you want to learn more about how to take advantage of opportunities created by the Covid crisis

Message me on Linkedin and check our latest commercial listings:

Broderick Realty Commercial Listings

https://www.linkedin.com/in/carldilley/

Please subscribe to our newsletter to get ongoing Real Estate and Alternative Investing updates:

Black Swan Connection Newsletter Signup

November 19, 2021
COMPANY QUOTES, LISTINGS RESEARCH AND NEWS  
Antibe Therapeutics, Inc (ATBPF)  Profile 11/11/2018 News
Can B Corp (CANB) Profile News
Endurance Exploration Group, Ltd (EXPL)  Profile   03-26/19 News
Social Reality, Inc. (SRAX) Profile 02/05/19 News
Apollo Future Mobility Ltd. (HK 0860) Profile 2/23/2020 News              

Novembver 19, 2021

ValuEngine Weekly Report

By: Herb Blank

Active ETF Gurus vs. GURU Index ETF
This week’s featured ETF is GURU, Global X Guru Index based on a specific “smart money” hedge fund strategy. Guru’s site claims that the index engineered by Global X and provided by German customized index specialist Solactive AG allows everyday investors to access the high conviction investments among the largest, most sophisticated hedge funds in the world. It uses a proprietary methodology to access the highest conviction ideas from a select pool of hedge funds where the 13F holdings information is most valuable. In other words, GURU “indexizes” an active strategy to capitalize on changes in the quarterly holding positions of Hedge Fund “gurus.” Its objective is to serve as an alpha sleeve rather than as a diversified core equity holding.
All of the approximately 5,000 stocks, 16 sector groups, 140 industries, and 500 ETFs have been updated on www.ValuEngine.com

Read Complete Report

To subscribe to our bulletins and receive content whenever it is published, subscribe at our blog HERE

Want to learn more about ValuEngine? Our methods? Our history? 
Check out our video presentation HERE

SMM Research Partners

Black Swan Research Coverage and Subscription Service
Click Here>>

Event Calendar Updates

Not Surprisingly many conference events are cancelled or postponed- but are now getting back in action.

Rocky Mountain Microcap Conference VIII.

November 3,  2021 at TopGolf in Centennial Colorado. 

We’ll have some updates on the event soon

LD Micro Main Event
October 12-14  Los Angeles.

This conference was a great success

All presenting company video calls will be available to view for 3 months. Visit the event website to see all the presentations: https://ldmicrojune2021.mysequire.com/

Check the website for updates:

https://www.ldmicro.com/

Visit our homepage for up to the minute Financial News, Quotes and our Latest Black Swan Connection Newsletter

Stock Market Manager Homepage

-SMM Distribution Update-

Distribution (Reach)

SMM Global Twitter Acct     (Impressions last 30 days)          520

SMM Global Facebook Page  (Reach last-30 days)               6,462

SMM Linkedin Pages                 (contacts)                          1,100

SMM Youtube Channel            (followers)                                 6 

SMM Instagram Page  *          (followers)                               11

Direct Email     *                                                          220,000

Total                                                                           256,460

Black Swan Connection Newsletter Signup

ABOUT US